Anticoagulant News and Research

RSS

New combined risk score shows improved effectiveness in predicting stroke risk of Afib patients

Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib.

11 May 2018

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

HORIBA UK Ltd, Medical announces a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

From HORIBA Medical 11 May 2018

New studies could offer novel treatments for vision and eye conditions

Three new studies demonstrate research findings that could offer novel treatments for vision and eye conditions.

30 Apr 2018

Popular ASRA Coags app helps physicians protect patients taking anticoagulants

The popular ASRA Coags app has just been updated to combine the latest regional anesthesia/acute pain medicine and chronic pain medicine drugs, procedures, and interventions.

16 Apr 2018

Using Cord Blood to Alleviate the Symptoms of Autism

Cord blood has been studied extensively for the treatment of hematological diseases such as cancer and sickle cell anemia, but is now in phase II trials for the alleviation of autism. Dr. Ann Smith, director of Smart Cells who provided the cord blood for the trial, discusses the research and it's potential.

9 Apr 2018

Anticoagulant drugs found safe to use in patients undergoing surgery for irregular heartbeat

A trial led by the University of Birmingham has found that two types of blood thinning drugs are safe to use in patients with an irregular heartbeat when they are undergoing surgery aimed at stopping the condition.

21 Mar 2018

Atrial fibrillation patients could reduce risk of dementia by taking stroke prevention drugs

Patients with atrial fibrillation could reduce the risk of dementia by taking stroke prevention medications, according to recommendations published online today in EP Europace, a European Society of Cardiology journal, and presented at EHRA 2018.

19 Mar 2018

Self-adhering chest patch may better detect common heart rhythm disorder than usual care

For people at heightened risk for atrial fibrillation —a common heart rhythm disorder that also carries a high risk of stroke—wearing a self-adhering chest patch that records heart patterns may better detect the condition and facilitate more timely treatment than relying on usual care, according to one-year data being presented at the American College of Cardiology's 67th Annual Scientific Session.

12 Mar 2018

Annual foot screening could help spot heart irregularities in people with diabetes

This National Heart Month (February) leading podiatrists across the North East are calling for people with diabetes to go for their annual footcheck, as findings show it could prevent the risk of stroke.

24 Feb 2018

Clinical trial shows safety of promising TSRI stroke drug

A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps Research Institute.

20 Feb 2018

Study finds higher risk of stroke among blacks with atrial fibrillation than whites

Blacks have a higher incidence of stroke and stroke-associated disability than whites. However, few studies have evaluated racial differences in stroke before a diagnosis of atrial fibrillation (AF).

20 Feb 2018

New clinical practice guideline provides recommendations for use of anticoagulants during heart surgery

The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology released a new clinical practice guideline that includes major recommendations for the use of blood thinning medication (anticoagulants) during heart surgery.

22 Jan 2018

Study finds higher risks for asymptomatic paroxysmal AF patients

Atrial fibrillation (AF) can often be asymptomatic, leading to difficulties in diagnosis and untreated risks for morbidity and mortality.

18 Jan 2018

Researchers identify new anti-inflammatory drug target

A new study suggests that parmodulins may provide anti-inflammatory and anti-thrombotic protection to endothelial cells, without interfering with clotting.

16 Jan 2018

New study enrolls first patient to evaluate potential of WaveCrest LAAO System

Johnson & Johnson Medical Devices Companies today announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled the first patient in the WaveCrest Investigational Device Exemption Trial.

16 Jan 2018

Global study on stroke prevention in high-risk AF patients

The largest global clinical study on the best-possible therapy for patients with atrial fibrillation at high risk of having a stroke and at increased risk of bleeding is starting at the German Centre for Cardiovascular Research.

12 Jan 2018

Younger persons newly-diagnosed with type 2 diabetes have poorer health than older patients

The common view of type 2 diabetes as an old person's disease is becoming seriously outdated in step with the increasing number of persons under the age of 45 who develop the disease.

13 Dec 2017

New, more easily administered therapies offer benefits for bleeding and clotting disorders

In three studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report remarkable benefits from new, more easily administered therapies for bleeding and clotting disorders.

11 Dec 2017

Shorter course of radiation may be preferred treatment for men with intermediate-risk prostate cancer

Prostate cancer is the most common cancer among males in the United States. Approximately, 180,000 men are diagnosed each year, and approximately 95 percent of these men have localized disease that is potentially curable.

5 Dec 2017

New strategy offers therapeutic alternative to prevent excessive clotting in kidney disease patients

Researchers at Boston University School of Medicine have discovered a potential treatment target to prevent chronic kidney disease patients from developing blood clots without causing bleeding complications - an unwanted and perplexing side effect.

29 Nov 2017